Section Arrow
EMI.NYSE-M
- Encore Medical Inc.
Quotes are at least 15-min delayed:2026/04/29 13:07 EDT
Regular Hours
Last
 --
-- (--)
Day High 
-- 
Prev. Close
-- 
1-M High
-- 
Volume 
-- 
Bid
--
Ask
--
Day Low
-- 
Open
-- 
1-M Low
-- 
Market Cap 
-- 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High -- 
52-W Low -- 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-0.10/--
Enterprise Value
--
Balance Sheet
Book Value Per Share
N/A
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
GCTKGlucoTrack Inc1.0051+0.1681+20.08%-- 
AVTRAvantor7.665-0.195-2.48%-- 
BAXBaxter International17.175-0.765-4.26%-- 
XRAYDENTSPLY SIRONA11.555-0.225-1.91%-- 
NVSTEnvista Holdings Corp26.03-0.46-1.74%94.61PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Encore Medical Inc develops, manufactures, and markets septal occlusion devices for the repair of certain cardiac defects. Its products have been implanted in approximately 35,000 patients outside the United States. Its closure device is designed to correct a cardiac defect, generally diagnosed in adulthood, known as a patent foramen ovale (PFO). The company also currently market and sell septal occlusion devices for the transcatheter closure of atrial septal defects (ASD).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.